Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 12, 2015, Pages 1753-1758

  Ding, Wen Jin ^a   Wang, Man Man ^b   Wang, Gong Sui ^c   Shen, Fen ^a   Qin, Jian Jun ^a   Fan, Jian Gao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c SHUNDE HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic steatosis; Hepatitis B virus; Thyroid function

Indexed keywords

BIOLOGICAL MARKER; THYROTROPIN;

ADULT; BLOOD; CHRONIC HEPATITIS B; COMPLICATION; FATTY LIVER; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; BIOMARKERS; FATTY LIVER; FEMALE; HEPATITIS B, CHRONIC; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; THYROTROPIN;

EID: 84954426916     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12998     Document Type: Article

References (31)

1. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet 2014; 384: 2053-2063.
2. Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology 2014; 60: 2099-2108.
3. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2007; 25: 883-889.
4. Eguchi Y, Hyogo H, Ono M etal. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J. Gastroenterol. 2012; 47: 586-595.
5. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 2009; 50: 204-210.
6. Rastogi A, Sakhuja P, Kumar A etal. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J. Pathol. Microbiol. 2011; 54: 454-459.
7. Nau AL, Soares JC, Shiozawa MB, Dantas-Corrêa EB, Schiavon Lde L, Narciso-Schiavon JL. Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic HBV carriers. Rev. Soc. Bras. Med. Trop. 2014; 47: 158-164.
8. Wong VW, Wong GL, Chu WC etal. Hepatitis B virus infection and fatty liver in the general population. J. Hepatol. 2012; 56: 533-540.
9. Maratou E, Hadjidakis DJ, Kollias A etal. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur. J. Endocrinol. 2009; 160: 785-790.
10. Liangpunsakul S, Chalasani N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? J. Clin. Gastroenterol. 2003; 37: 340-343.
11. DiDomenicantonio A, Politti U, Marchi S etal. A review on thyroid autoimmune disorders and HCV chronic infection. Clin. Ter. 2014; 165: e376-381.
12. Kleiner DE, Brunt EM, Van Natta M etal. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology 2005; 41: 1313-1321.
13. ChineseSociety of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Zhonghua Gan Zang Bing Za Zhi 2011; 19: 13-24.
14. Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J. Gastroenterol. Hepatol. 2011; 26: 1361-1367.
15. Chung GE, Kim D, Kim W etal. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J. Hepatol. 2012; 57: 150-156.
16. Silveira MG, Mendes FD, Diehl NN, Enders FT, Lindor KD. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. Liver Int. 2009; 29: 1094-1100.
17. Pagadala MR, Zein CO, Dasarathy S, Yerian LM, Lopez R, McCullough AJ. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Dig. Dis. Sci. 2012; 57: 528-534.
18. Xu C, Xu L, Yu C, Miao M, Li Y. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin. Endocrinol. (Oxf) 2011; 75: 240-246.
19. Zhang J, Sun H, Chen L etal. Relationship between serum TSH level with obesity and NAFLD in euthyroid subjects. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2012; 32: 47-52.
20. Pacifico L, Bonci E, Ferraro F, Andreoli G, Bascetta S, Chiesa C. Hepatic steatosis and thyroid function tests in overweight and obese children. Int J Endocrinol. 2013; 2013: 381014.
21. Dimitriadis G, Mitrou P, Lambadiari V etal. Insulin action in adipose tissue and muscle in hypothyroidism. J. Clin. Endocrinol. Metab. 2006; 91: 4930-4937.
22. Rochon C, Tauveron I, Dejax C etal. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clin. Sci. 2003; 104: 7-15.
23. Raftopoulos Y, Gagné DJ, Papasavas P etal. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes. Surg. 2004; 14: 509-513.
24. Misra S, Singh B. Insulin resistance and hypothyroidism: a complex relationship in non-alcoholic fatty liver disease. J. Indian Med. Assoc. 2013; 111: 324-326, 329.
25. Kabir A. Decreased serum total T3 level in hepatitis B and C related cirrhosis by severity of liver damage. Ann. Hepatol. 2013; 12: 506-507.
26. Hassan MM, Kaseb A, Li D etal. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 2009; 49: 1563-1570.
27. Antonelli A, Ferri C, Fallahi P etal. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 2006; 16: 563-572.
28. Blackard JT, Kong L, Huber AK, Tomer Y. Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of HCV and thyroiditis. Thyroid 2012; 23: 863-870.
29. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F etal. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch. Intern. Med. 1998; 158: 1445-1448.
30. Kansu A, Kuloğlu Z, Demirçeken F, Girgin N. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha. Turk. J. Gastroenterol. 2004; 15: 213-218.
31. Eshraghian A, Dabbaghmanesh MH, Eshraghian H, Fattahi MR, Omrani GR. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch. Iran. Med. 2013; 16: 584-589.